DMYD-B:STO
Diamyd Medical AB
SEKÂ 1.02
arrow_downward
-0.59%(-0.0060) 1D
Oct 2, 5:23:12 PM GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DMYD-B...
Open
SEKÂ 1.02
High
SEKÂ 1.03
Low
SEKÂ 1.00
Mkt. cap
154.21M
Avg. vol.
724.59K
Volume
243.21K
52-wk high
SEKÂ 17.88
52-wk low
SEKÂ 0.90
EPS
-SEKÂ 1.98
Shares outstanding
134.00M
No. of employees
44
Open
SEKÂ 1.02
High
SEKÂ 1.03
Low
SEKÂ 1.00
Mkt. cap
154.21M
Avg. vol.
724.59K
Volume
243.21K
52-wk high
SEKÂ 17.88
52-wk low
SEKÂ 0.90
EPS
-SEKÂ 1.98
Shares outstanding
134.00M
No. of employees
44
News stories
From web sources and news partners
ChartMill
·
28 minutes ago
S&P 500 Most Active Stocks in Today's US Session
ETF Database
·
2 hours ago
S&P 500 Snapshot: Stocks Rally to Close Out Flat Week
TradingView
·
5 hours ago
Nasdaq rises for the week as Lumentum leads gains
BigGo Finance
·
3 hours ago
Dow extends gains, rises 250 points to 51,176 as jobs report cools rate-hike bets
Profile
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for type-1 diabetes. The company's investigational drug retogatein is based on a recombinant form of GAD₆₅, one of two human glutamate decarboxylase gene products.
The company is headquartered in Stockholm, and maintains a "biomanufacturing" facility in Umeå which utilizes bacuolavirus-mediated protein expression. Wikipedia
About Diamyd Medical AB